Skip to content
EntityQ21099046· pop 17· linked from 184 articles

finerenone

Sign in to save

Also known as BAY 94-8862

Finerenone, marketed under the brand name Kerendia among others, is a medication used to reduce the risk of kidney function decline, kidney failure, cardiovascular death, non-fatal, non-fatal myocardial infarctions, and hospitalization for heart failure in adults with chronic kidney disease associated with type2 diabetes. In the United States, it is also approved to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits in adults with heart failure and a left ventricular ejection fraction (LVEF) of 40% or greater. Finerenone is a non-steroid

Key facts

Drug.image
Finerenone.svg
Drug.image_class
skin-invert-image
Drug.tradename
Kerendia
Drug.MedlinePlus
a621038
Drug.DailyMedID
Finerenone
Drug.pregnancy_AU
D
Drug.routes_of_administration
Oral
Drug.class
Potassium-sparing diuretic
Drug.ATC_prefix
C03
Drug.ATC_suffix
DA05
Drug.legal_AU
S4
Drug.legal_CA
Rx-only
Drug.legal_US
Rx-only
Drug.legal_EU
Rx-only
Drug.CAS_number
1050477-31-0
Drug.PubChem
60150535
Drug.DrugBank
DB16165
Drug.ChemSpiderID
28669387

via Wikipedia infobox

Wikidata facts

Mass
378.169191
Show 4 more facts
chemical formula
C₂₁H₂₂N₄O₃
isomeric SMILES
CCOC1=NC=C(C2=C1[C@@H](C(=C(N2)C)C(=O)N)C3=C(C=C(C=C3)C#N)OC)C
canonical SMILES
CCOC1=NC=C(C2=C1C(C(=C(N2)C)C(=O)N)C3=C(C=C(C=C3)C#N)OC)C
Commons category
Finerenone
Sources (3)

via Wikidata · CC0

~5 min read

Article

9 sections
Contents
  • Medical uses
  • Pharmacology
  • Adverse effects
  • History
  • Legal status
  • Brand names
  • Research
  • References
  • Further reading

Finerenone, marketed under the brand name Kerendia among others, is a medication used to reduce the risk of kidney function decline, kidney failure, cardiovascular death, non-fatal, non-fatal myocardial infarctions, and hospitalization for heart failure in adults with chronic kidney disease associated with type2 diabetes. In the United States, it is also approved to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits in adults with heart failure and a left ventricular ejection fraction (LVEF) of 40% or greater. Finerenone is a non-steroidal mineralocorticoid receptor antagonist. It is taken orally (swallowed by mouth).

Common side effects include abnormally high levels of potassium in the bloodstream, abnormally low levels of sodium in the bloodstream, and abnormally low blood pressure.

Connections

Categories